Patent · US Active

Methods of producing adalimumab

US9284371B2 · kind B2 · utility

23Cited by
70References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 22, 2015
Grant dateMar 15, 2016
Priority date
Expiry dateOct 22, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2511/00
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention describes improved methods and compositions for producing a recombinant protein, e.g., an antibody, in mammalian cell culture. In addition, the invention provides improved cell culture media, including improved production media, feed solutions, and combination feeds, which may be used to improve protein productivity in mammalian cell culture.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.